Bristol-Myers enters into immuno-oncology collaboration with Ono Pharmaceutical
Ampio Pharmaceuticals announce opening of new headquarters, manufacturing, research facility in Englewood, Colorado
Allergan announces earnings and restructuring/layoffs, while still fighting Valeant
AbbVie and Shire - latest on the merger
Visit our sites for b2b sales and banking employees:
Submit an article to cafepharma's CP Wire. Click here to find out more.
| Company | Average | Last 24h |
Increase |
|---|---|---|---|
| BGI | 2 | 15 | 650 % |
| Biogen Idec | 10 | 64 | 540 % |
| Medicis | 1 | 5 | 400 % |
| Ligand Pharmaceuticals | 1 | 5 | 400 % |
| ViiV Healthcare | 5 | 22 | 340 % |
| Andover Healthcare | 2 | 8 | 300 % |
| Amgen | 2 | 8 | 300 % |
| McKesson | 1 | 4 | 300 % |
| Diagnos | 1 | 4 | 300 % |
| Charles River Laboratories | 2 | 8 | 300 % |
| Company | Average | Last 24 hrs |
Increase |
|---|---|---|---|
| Utah Medical Products | 1 | 12 | 1100 % |
| CorMedix | 2 | 22 | 1000 % |
| OncoGenex | 2 | 17 | 750 % |
| Pacific Biosciences | 3 | 25 | 733 % |
| TapImmune | 3 | 24 | 700 % |
| CompuGen | 4 | 31 | 675 % |
| China Pharmaceutical | 12 | 86 | 617 % |
| Ono Pharmaceutical | 10 | 69 | 590 % |
| Cryolife | 4 | 27 | 575 % |
| AtriCure | 5 | 33 | 560 % |